CL
77
2
SLB
48
2
CHK
5
-7
CA
40
4
DNB
36
2
HRL
29
2
VMC
57
3
SNA
53
-3
PEG
41
-3
ILMN
36
10
AKAM
48
-11
GOOGL
67
3
FLR
36
-3
BF.B
53
5
HCA
55
2
NVDA
60
-5
NTRS
39
2
CRM
59
4
ADM
36
2
MDLZ
36
4
CL
77
2
SLB
48
2
CHK
5
-7
CA
40
4
DNB
36
2
HRL
29
2
VMC
57
3
SNA
53
-3
PEG
41
-3
ILMN
36
10
AKAM
48
-11
GOOGL
67
3
FLR
36
-3
BF.B
53
5
HCA
55
2
NVDA
60
-5
NTRS
39
2
CRM
59
4
ADM
36
2
MDLZ
36
4
Financhill
Back

Collegium Pharmaceutical Quote, Financials, Valuation and Earnings

Sell
30

COLL
Collegium Pharmaceutical

Last Price:
31.67
Seasonality Move:
-4.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Collegium Pharmaceutical Price Quote

$31.67
-0.01 (0.29%)
(Updated: June 22, 2024 at 5:35 AM ET)

Collegium Pharmaceutical Key Stats

Sell
30
Collegium Pharmaceutical (COLL) is a Sell
Day range:
$31.42 - $32.07
52-week range:
$20.83 - $40.95
Dividend yield:
0%
P/E ratio:
24.56
P/S ratio:
2.63
P/B ratio:
4.67%
Volume:
1.2M
Avg. volume:
607.6K
1-year change:
34.01%
Market cap:
$1B
Revenue:
$566.8M
EPS:
$2.41

How Much Does Collegium Pharmaceutical Make?

Is Collegium Pharmaceutical Growing As A Company?

Collegium Pharmaceutical Stock Price Performance

What Is Collegium Pharmaceutical 52-Week High & Low?

Collegium Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Collegium Pharmaceutical?

Is Collegium Pharmaceutical Cash Flow Positive?

  • What Is COLL Cash Flow From Operations?
    Cash flow from operations (TTM) is $309M
  • What Is Collegium Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$262.6M
  • What Is Collegium Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$88.8M

Collegium Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    COLL return on invested capital is 10.29%
  • What Is Collegium Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 7.96%
  • What Is COLL Return On Equity?
    ROE is a measure of profitability and is 47.75%

Collegium Pharmaceutical Earnings Date & Stock Price

Collegium Pharmaceutical Competitors

Collegium Pharmaceutical Dividend Yield

Data Unavailable

Collegium Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -1.36%
Revenue: 0.11% -1.37%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 41.00
Upside from Last Price: 29.42%

Major Shareholders

  • How many COLL shares are owned by institutional investors?
    55.9M COLL shares are owned by institutional investors
  • How many COLL shares are owned by insiders?
    1.9M COLL shares are owned by insiders